Aligos Therapeutics Inc. (ALGS)
undefined
undefined%
At close: undefined
34.67
1.55%
After-hours Dec 13, 2024, 07:59 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Net Income -87.68M -96.05M -128.33M -108.54M -52.26M -13.93M
Depreciation & Amortization 3.07M 3.67M 3.78M 3.33M 2.30M 1.29M
Stock-Based Compensation 12.65M 14.69M 13.46M 2.98M 752.00K 179.00K
Other Working Capital -7.31M -3.27M -4.34M 16.19M 3.29M 1.91M
Other Non-Cash Items 2.49M -159.00K 86.00K 11.39M -1.23M 1.64M
Deferred Income Tax - - - 530.00K - -110.00K
Change in Working Capital -9.53M -1.55M -4.65M 16.06M 3.67M 4.88M
Operating Cash Flow -79.00M -79.39M -115.66M -74.26M -46.77M -6.05M
Capital Expenditures -19.00K -943.00K -892.00K -2.06M -2.79M -2.52M
Acquisitions - 25.35M -3.91M -34.82M -9.58M -
Purchase of Investments -11.00K -104.27M -19.09M -45.28M -70.42M -66.77M
Sales Maturities Of Investments 45.01M 78.92M 23.00M 80.10M 80.00M -
Other Investing Acitivies - -25.35M 3.91M 34.82M 9.58M -72.84M
Investing Cash Flow 44.98M -26.29M 3.02M 32.76M 6.79M -69.29M
Debt Repayment -96.00K -61.00K -79.00K -58.00K -43.00K 5.00M
Common Stock Repurchased - - - - - -
Dividend Paid - - - - - -
Other Financial Acitivies 70.98M 225.00K 172.00K 40.00M 85.58M 94.88M
Financial Cash Flow 88.33M 164.00K 78.68M 192.35M 85.53M 99.89M
Net Cash Flow 54.31M -105.52M -33.96M 150.84M 45.56M 24.55M
Free Cash Flow -79.02M -80.33M -116.55M -76.33M -49.55M -8.56M